Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOT Reactance for Bronchodilator Response in COPD
NCT03910985Phase 4Unknown
- Sponsor
- CHU UCLouvain Namur
- Start
- Apr 2019
- Primary completion
- Dec 2021
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
Phase 4, open-label, single-arm trial of Combivent in chronic obstructive pulmonary disease (COPD), sponsored by CHU UCLouvain Namur. Primary endpoint: Acute inspiratory capacity increase. Status: unknown.
02
Drugs
Combivent
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03910985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03910985.